Corporate Sponsors - _old_Renal Healthcare Association

Corporate Sponsors

Thank you to our Corporate Sponsors for their continued support of Renal Healthcare Association. With your partnership, we are able to continue our mission to support independent and community-based dialysis providers through education, advocacy, and services.

If your company would like to support Renal Healthcare Association in a greater capacity and elevate your presence among the renal care community, we encourage you to become a Corporate Sponsor as well. Annual sponsorship opportunities are offered in four tiers: Platinum, Gold, Silver, and Bronze. Additionally, a new Start-Up Level has been added for companies founded within the last three years. Click here to learn more about becoming a Corporate Partner with Renal Healthcare Association.

Platinum Level Sponsors


	AKEBIA THERAPEUTICS Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit www.akebia.com.


	ARDELYX Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA^® (tenapanor) and XPHOZAH^® (tenapanor) as well as early-stage pipeline candidates. Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin has received approval for PHOZEVEL^® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

	ASCEND CLINICAL Ascend Clinical is the nation's leading independent laboratory dedicated exclusively to dialysis and kidney disease testing. With more than 35 years of experience, the company provides fast, accurate laboratory results, a renal-specialized team, and exceptional client support to dialysis providers nationwide. Its fully automated laboratory and advanced technology enable rapid turnaround times, helping clinics deliver timely, high-quality care for patients across the continuum of kidney disease. Headquartered in Sunnyvale, California, Ascend Clinical serves independent and hospital-based dialysis providers throughout the United States. For more information, visit www.aclab.com.

Gold Level Sponsors

AMGEN

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

FRESENIUS MEDICAL CARE
Fresenius Medical Care is not your typical medical products company. We are a close-knit team of talented professionals driven by a shared commitment: to lead a movement to dramatically improve renal care with innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. We pursue this goal through a passionate commitment to Innovate, Educate and Advocate for the breakthroughs that are redefining renal care. Additionally, Fresenius works in community with its customers, patients, industry partners, and government leaders and agencies to realize the vision of better, simpler, more accessible renal care.

For more information, please visit fmcna.com.

Silver Level Sponsors

	CARDINAL HEALTH Through Cardinal Health, dialysis centers and nephrology practices gain access to a broad portfolio of renal-related pharmaceuticals and supplies, home dialysis solutions, competitive pricing via Renal Purchasing Group™ GPO, and exclusive distribution through Metro Medical™ Distribution Services. To learn more, visit www.cardinalhealth.com/nephrology.
	CSL VIFOR CSL Vifor is a global pharmaceutical company that researches, develops, produces and markets its own pharmaceutical products. Poised to be a global leader in iron deficiency, nephrology and cardio-renal therapies, Vifor strives to help patients around the world with severe and chronic diseases to lead better, healthier lives. For more information, please visit www.viforpharma.com.
	DIALITY Diality is developing a smart, versatile hemodialysis system designed to be as capable as in-center systems while also easy to learn and use in any chronic or acute dialysis environment. The Diality system offers flexibility to tailor treatment to each patient’s specific needs, regardless of modality and care setting, and empowers kidney care providers to choose what is right for their patients and practices during this time of unprecedented change in the care of patients with kidney disease. For more information, visit https://www.diality.com/.
	NATIONAL DIALYSIS ACCREDITATION COMMISSION National Dialysis Accreditation Commission is an Accreditation Organization (AO) specializing in the dialysis industry. NDAC was the first AO in the U.S. to be approved by CMS for deemed status for End-Stage Renal Disease. Dialysis providers successfully completing NDAC's accreditation process can be awarded Medicare certification from CMS based on their accreditation with a recommendation for deemed status by NDAC. Based in Glen Ellyn, Illinois, NDAC offers accreditation services in all 50 United States and U.S. territories. NDAC's owners and executive leadership are experts and thought leaders with a long track record of success in ESRD, which is why NDAC provides Dialysis Accreditation by Dialysis Experts©. For more information about NDAC, please visit www.ndacommission.com/.
	UNICYCIVE Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate-binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information, please visit Unicycive.com.

	VANTIVE HEALTHCARE Vantive Healthcare is a leader in renal home therapies through its products for peritoneal dialysis (PD), providing solutions, devices and services for end-stage kidney disease patients. Vantive also distributes products for in-center hemodialysis. For more information, visit https://www.vantive.com/.

.

RHA Partners

NEPHROLOGY NEWS & ISSUES
Nephrology News & Issues is a peer-reviewed national news magazine that takes a global approach to covering the political, social, and economic issues surrounding the delivery of dialysis and transplant care. The magazine's website, www.healio.com/nephrology, provides daily updates on healthcare news that impacts renal care.